DKSC (Dakshidin) Beginning Cash Position: $0.00 Mil (As of Sep. 2023)


What is Dakshidin Beginning Cash Position?

Dakshidin DKSC +33.33% Beginning Cash Position is $0.00 Mil as of Sep. 2023.

Dakshidin's Beginning Cash Position for the quarter that ended in Sep. 2023 was $0.00 Mil.

Dakshidin's quarterly Beginning Cash Position declined from Mar. 2020 ($0.00 Mil) to Sep. 2022 ($0.00 Mil) but then stayed the same from Sep. 2022 ($0.00 Mil) to Sep. 2023 ($0.00 Mil).


Dakshidin Beginning Cash Position Related Terms


Dakshidin Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Dakshidin's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dakshidin Beginning Cash Position Chart

Dakshidin Annual Data
Trend
Beginning Cash Position

Dakshidin Quarterly Data
Mar19 Mar20 Sep22 Sep23
Beginning Cash Position 0.00 0.00 0.00 0.00

Dakshidin Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $0.00 Mil mean?
Dakshidin (DKSC) has a Beginning Cash Position of $0.00 Mil as of Sep. 2023. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Dakshidin and its competitors.
Is Dakshidin's Beginning Cash Position too high?
Dakshidin's current Beginning Cash Position is $0.00 Mil.
How does Dakshidin's Beginning Cash Position compare to ECEZ and AFBG?
Dakshidin's Beginning Cash Position of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Drug Manufacturers company?
A good Beginning Cash Position depends on the Drug Manufacturers industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Dakshidin and its competitors. Dakshidin's current Beginning Cash Position is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dakshidin stock overvalued right now?
Dakshidin (DKSC) has a current Beginning Cash Position of $0.00 Mil. The current Beginning Cash Position is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Dakshidin (DKSC), the current Beginning Cash Position is $0.00 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dakshidin Business Description

Address 508 Locust Street, Lockport, NY, USA, 14094
Dakshidin Corp is a Cannabis-based medical product company. The company operates through its online e-commerce store laughingfrogs.com. The company is composed of four synergistic entities: Laughing Frogs, an online sales portal for the company's CBD products; Laughing Frogs Nutraceutical the online sales portal for all non-CBD hemp oil products and its proprietary nutraceutical products, company's new PPE division and Runnymede Farms, a company that is focused on the cultivation of specifically grown Hemp plants. through its growing operations and Joint Ventures with established growers.